Related Experiment Video
Updated: Aug 10, 2026
09:31
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
[Blood serum protein study in oncological patients]
Voprosy Onkologii
|January 1, 1978
Summary
This study reveals distinct blood serum protein spectrum differences in cancer patients compared to healthy donors. These proteinograph variations may aid in diagnosing ovarian and endometrial cancers.
Area of Science:
- Biochemistry
- Oncology
- Proteomics
Background:
- Blood serum protein spectrum analysis is crucial for understanding physiological and pathological states.
- Cancerous conditions are known to alter protein expression profiles in bodily fluids.
Purpose of the Study:
- To investigate and identify differences in the blood serum protein spectrum between patients with ovarian and endometrial cancer and healthy female donors.
- To explore the potential diagnostic utility of observed proteinographic variations.
Main Methods:
- Analysis of blood serum protein spectrum using the Điệnфорез в полиакриламидном геле (PAAG) method.
- Separation and quantification of 27 distinct protein fractions.
- Comparative analysis of proteinograms between cancer patients and a control group of female donors.
Main Results:
- Significant decreases (30-90%) in protein levels were observed in fractions 4, 9, and 26 in cancer patients.
- Significant increases (25-100%) in protein levels were noted in fractions 15, 16, 18, and 22 in cancer patients.
- A specific fraction (Rt 2.10) in the prealbumin zone was frequently detected in cancer patients but rarely in donors.
Conclusions:
- The identified differences in blood serum proteinograms between cancer patients and healthy individuals are statistically significant.
- These proteinographic alterations hold potential as biomarkers for the diagnosis of ovarian and endometrial cancers.
- Further comparative studies across different cancer localizations could refine diagnostic applications.
